Clinical Trials Logo

Mastodynia clinical trials

View clinical trials related to Mastodynia.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT05548374 Recruiting - Acupuncture Clinical Trials

Acupuncture for Breast Pain

Start date: March 1, 2023
Phase: N/A
Study type: Interventional

This study is conducted to assess the efficacy and safety of acupuncture in moderate to severe cyclic breast pain.

NCT ID: NCT05494502 Recruiting - Chronic Pain Clinical Trials

Impact of Erector Spinae Plane Block on Chronic Postsurgical Pain in Breast Cancer Patients

Start date: May 23, 2023
Phase: N/A
Study type: Interventional

Chronic postsurgical pain (CPSP) has an incidence of 46% in patients after breast cancer surgery, which seriously affects patients' physiological and psychological function, as well as quality of life. Acute pain is an independent risk factor for persistent pain after surgery. Erector spinae plane block (ESPB) provided excellent perioperative analgesia in patients undergoing breast surgery. Dexmedetomidine as an adjuvant of local anesthetics prolongs the duration of peripheral nerve block and decreases the requirements of postoperative analgesia. The investigators hypothesize that, for breast cancer patients undergoing mastectomy, ESPB (with a combination of 0.5% ropivacaine 35 ml and dexmedetomidine 1 microgram/kg) can reduce the occurrence of CPSP. The purpose of this randomized controlled trial is to investigate the impact of ESPB with adjuvant dexmedetomidine on the incidence of CPSP in breast cancer patients after mastectomy. We will also observe the impact of ESPB on long-term survival in these patients.

NCT ID: NCT05494281 Recruiting - Pain, Postoperative Clinical Trials

Serratus Anterior Plane Block to Prevent Chronic Postoperative Pain in Breast Cancer

USB22
Start date: August 1, 2022
Phase: N/A
Study type: Interventional

Chronic postoperative pain (CPP) remains a disturbing and obscure clinical problem. The hypothesis of this trial is that a peripheral block of the serratus anterior plane block type preoperatively after a modified radical mastectomy makes it possible to reduce the intensity and incidence of chronic post-surgical pain in breast cancer.

NCT ID: NCT05408377 Recruiting - Mastalgia Clinical Trials

Effectiveness of Acupuncture for Cyclical Mastalgia (CM)

Start date: July 20, 2022
Phase: N/A
Study type: Interventional

This study is a multi-center 2-arm randomized controlled trial. According to the ratio of 1:1 and block randomization, a total of 108 eligible CM patients will be randomly allocated to either MA(n=54) or SA(n=54). All patients will undergo treatment two weeks before menstruation and treatment will be stopped at the onset of menstruation. Three times a week, six times a menstrual cycle, 3consecutive menstrual cycles for a total of 18 sessions after baseline. The primary outcome will be the change in the average daily breast pain VAS(VAS-BP) scores during the first 2 weeks of menstruation from baseline at weeks 4,8,12. Additionally, VAS-BP scores at weeks 24 and 36 will also be assessed. Secondary outcomes will include the number of nominal days of breast pain (NDBP) 2 weeks before menstruation, WHOQOL-BREF scores, patient global assessment, breast glandular section thickness, and breast duct width three days before menstruation from baseline at weeks 12. This study will evaluate the effectiveness and safety of acupuncture to alleviate cyclic breast pain and to further explore the possible mechanisms underlying the effect.

NCT ID: NCT04967352 Recruiting - Breast Cancer Clinical Trials

Predicting Chronic Pain Following Breast Surgery

Start date: July 19, 2021
Phase:
Study type: Observational

Breast surgery, which includes mastectomy, breast reconstructive surgery, or lumpectomies with sentinel node biopsies, may lead to the development of chronic pain and long-term opioid use. In the era of an opioid crisis, it is important to risk-stratify this surgical population for risk of these outcomes in an effort to personalize pain management. The opioid epidemic in the United States resulted in more than 40,000 deaths in 2016, 40% of which involved prescription opioids. Furthermore, it is estimated that 2 million patients become opioid-dependent after elective, outpatient surgery each year. After major breast surgery, chronic pain has been reported to develop anywhere between 35% - 62% of patients, while about 10% use long-term opioids. Precision medicine is a concept at which medical management is tailored to an individual patient based on a specific patient's characteristics, including social, demographic, medical, genetic, and molecular/cellular data. With a plethora of data specific to millions of patients, the use of artificial intelligence (AI) modalities to analyze big data in order to implement precision medicine is crucial. We propose to prospectively collect rich data from patients undergoing various breast surgeries in order to develop predictive models using AI modalities to predict patients at-risk for chronic pain and opioid use.

NCT ID: NCT04930575 Recruiting - Neck Pain Clinical Trials

Muscle Energy Technique Versus Mulligan Technique for Treating Neck Pain in Breast Feeding Women

Start date: March 1, 2021
Phase: N/A
Study type: Interventional

The purpose of this study will determine the effect of muscle energy technique versus mulligan technique on neck pain in breastfeeding women.

NCT ID: NCT04238377 Recruiting - Breast Cancer Clinical Trials

Post Mastectomy Pain Syndrome After Preoperative Stellate Ganglion Block for Breast Cancer Surgeries

Start date: December 26, 2017
Phase: N/A
Study type: Interventional

This study investigate the effect of pre-operative ultrasound guided stellate ganglion block with local anesthetic on the frequency of neuropathic pain syndromes in the first 6-month post cancer breast surgeries with axillary dissection.

NCT ID: NCT03708302 Recruiting - Clinical trials for Post-Op Complication

Serratus and Parasternal Infrapectoral Block for Breast Surgery.

Start date: July 1, 2019
Phase: N/A
Study type: Interventional

Effective pain control is important following breast surgery as it improves quality of recovery, decreases the risk of chronic pain development and reduction of overall health care cost. Current strategies of pain management for breast surgery include use of opioid medication or addition of regional anesthesia along with general anesthesia. Serratus block and parasternal infrapectoral blocks are newly developed fascial plane blocks that are technically easy to perform, effective and safe based on our daily clinical practice and published evidence. We are comparing the addition of serratus and parasternal infrapectoral nerve block with general anesthesia to a combination of placebo and general anesthesia for breast reduction surgery. We propose that this would result in an improved efficiency resulting in early hospital discharge and improve quality of patient care, following breast reduction surgery.

NCT ID: NCT03700177 Recruiting - Anesthesia, Local Clinical Trials

Ropivacaine 0,2% Plus Dexamethasone Versus Ropivacaine 0,2% Plus Placebo in Modified Pectoral Block

Start date: February 1, 2019
Phase: Phase 4
Study type: Interventional

To find out if dexamethasone used as adjuvant to ropivacaine, a long-lasting local anesthetic, prolongs the duration of modified pectoral nerve block in women undergoing breast surgery.